Free Trial
LON:ROQ

Roquefort Therapeutics (ROQ) Share Price, News & Analysis

Roquefort Therapeutics logo
GBX 1.44 +0.19 (+15.20%)
As of 07/3/2025 10:22 AM Eastern

About Roquefort Therapeutics Stock (LON:ROQ)

Key Stats

Today's Range
1.25
1.44
50-Day Range
1.33
2
52-Week Range
1.08
6.78
Volume
732,933 shs
Average Volume
2.15 million shs
Market Capitalization
£1.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ROQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ROQ Stock News Headlines

Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.
Roquefort Thera Share Chat (ROQ)
See More Headlines

ROQ Stock Analysis - Frequently Asked Questions

Roquefort Therapeutics' stock was trading at GBX 4.10 at the beginning of the year. Since then, ROQ shares have decreased by 64.9% and is now trading at GBX 1.44.

Roquefort Therapeutics plc (LON:ROQ) issued its quarterly earnings results on Wednesday, April, 30th. The company reported ($0.75) earnings per share for the quarter. Roquefort Therapeutics had a negative net margin of 57,057.07% and a negative trailing twelve-month return on equity of 29.57%.

Shares of ROQ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Roquefort Therapeutics investors own include Vislink Technologies (XGTI), AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX) and Abacus Health Products (ABAHF).

Company Calendar

Last Earnings
4/30/2025
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:ROQ
CIK
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.52 million
Net Margins
-57,057.07%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.66 thousand
Cash Flow
GBX 0.96 per share
Price / Cash Flow
1.49
Book Value
GBX 3.82 per share
Price / Book
0.38

Miscellaneous

Free Float
N/A
Market Cap
£1.83 million
Optionable
Not Optionable
Beta
0.05
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:ROQ) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners